Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects With Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

NCT04703192 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04703192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04703192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects With Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 3, 2021
Completion date
August 31, 2027
Enrollment
155 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

adult t cell leukemia/lymphoma, relapsed/refractory peripheral t-cell lymphoma